Cargando…

Peripheral BDNF: a candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia

BACKGROUND. Brain-derived neurotrophic factor (BDNF) is an important regulator of synaptogenesis and synaptic plasticity underlying learning. However, a relationship between circulating BDNF levels and brain activity during learning has not been demonstrated in humans. Reduced brain BDNF levels are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skilleter, A. J., Weickert, C. S., Vercammen, A., Lenroot, R., Weickert, T. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413857/ https://www.ncbi.nlm.nih.gov/pubmed/25162472 http://dx.doi.org/10.1017/S0033291714001925

Ejemplares similares

Testosterone Is Inversely Related to Brain Activity during Emotional Inhibition in Schizophrenia
por: Vercammen, Ans, et al.
Publicado: (2013)

Common polymorphisms in dopamine-related genes combine to produce a ‘schizophrenia-like' prefrontal hypoactivity
por: Vercammen, A, et al.
Publicado: (2014)

Adjunctive selective estrogen receptor modulator increases neural activity in the hippocampus and inferior frontal gyrus during emotional face recognition in schizophrenia
por: Ji, E, et al.
Publicado: (2016)

Selective Estrogen Receptor Modulation Increases Hippocampal Activity during Probabilistic Association Learning in Schizophrenia
por: Kindler, Jochen, et al.
Publicado: (2015)

Disambiguating ventral striatum fMRI-related bold signal during reward prediction in schizophrenia
por: Morris, R W, et al.
Publicado: (2012)

Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume
por: Fillman, S G, et al.
Publicado: (2016)

M62. PERIPHERAL INFLAMMATION MARKERS IDENTIFY SUBSET OF PATIENTS WITH SCHIZOPHRENIA AND RELATED PSYCHOSES WHO HAVE INTELLECTUAL DECLINE FROM PREMORBID LEVELS
por: Weickert, Thomas, et al.
Publicado: (2020)

C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls
por: Jacomb, Isabella, et al.
Publicado: (2018)

Biomarkers in Schizophrenia: A Brief Conceptual Consideration
por: Weickert, Cynthia S., et al.
Publicado: (2013)

Frontal and Parietal Contributions to Probabilistic Association Learning
por: Rushby, Jacqueline A., et al.
Publicado: (2011)

Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia
por: Weickert, T W, et al.
Publicado: (2015)

Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders
por: Ray, M T, et al.
Publicado: (2014)

Raloxifene Improves Cognition in Schizophrenia: Spurious Result or Valid Effect?
por: Weickert, Thomas W., et al.
Publicado: (2017)

Brain antibodies in the cortex and blood of people with schizophrenia and controls
por: Glass, L J, et al.
Publicado: (2017)

Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder
por: Boerrigter, Danny, et al.
Publicado: (2017)

Potential Role of Oestrogen Modulation in the Treatment of Neurocognitive Deficits in Schizophrenia
por: Weickert, Thomas W., et al.
Publicado: (2016)

15. ON THE ROAD TO CURING SCHIZOPHRENIA
por: Weickert, Cynthia Shannon
Publicado: (2018)

Rethinking schizophrenia in the context of normal neurodevelopment
por: Catts, Vibeke S., et al.
Publicado: (2013)

The impact of premorbid and current intellect in schizophrenia: cognitive, symptom, and functional outcomes
por: Wells, Ruth, et al.
Publicado: (2015)

Differential effect of disease-associated ST8SIA2 haplotype on cerebral white matter diffusion properties in schizophrenia and healthy controls
por: Fullerton, Janice M., et al.
Publicado: (2018)

O1.5. ICAM-1 IS INCREASED IN BRAIN AND PERIPHERAL LEVELS OF SOLUBLE ICAM-1 IS RELATED TO COGNITIVE DEFICITS IN SCHIZOPHRENIA
por: Weickert, Thomas, et al.
Publicado: (2018)

Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia
por: Kindler, Jochen, et al.
Publicado: (2019)

Genetic variation in glutamatergic genes moderates the effects of childhood adversity on brain volume and IQ in treatment-resistant schizophrenia
por: Mohamed Saini, Suriati, et al.
Publicado: (2023)

Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases
por: Murphy, Caitlin E., et al.
Publicado: (2022)

Editorial: Schizophrenia: Human and Animal Studies
por: Moustafa, Ahmed A., et al.
Publicado: (2016)

White matter neuron biology and neuropathology in schizophrenia
por: Duchatel, Ryan J., et al.
Publicado: (2019)

Gene Expression Analysis Implicates a Death Receptor Pathway in Schizophrenia Pathology
por: Catts, Vibeke Sørensen, et al.
Publicado: (2012)

Lack of cortico-limbic coupling in bipolar disorder and schizophrenia during emotion regulation
por: Morris, R W, et al.
Publicado: (2012)

Cell proliferation is reduced in the hippocampus in schizophrenia
por: Allen, Katherine M, et al.
Publicado: (2015)

40.1 INFLAMMATORY CYTOKINES ARE ELEVATED IN THE MIDBRAIN IN SCHIZOPHRENIA
por: Purves-Tyson, Tertia, et al.
Publicado: (2018)

Peripheral Transcription of NRG-ErbB Pathway Genes Are Upregulated in Treatment-Resistant Schizophrenia
por: Mostaid, Md Shaki, et al.
Publicado: (2017)

The effect of adolescent testosterone on hippocampal BDNF and TrkB mRNA expression: relationship with cell proliferation
por: Allen, Katherine M, et al.
Publicado: (2015)

Neuroinflammation in schizophrenia: the role of nuclear factor kappa B
por: Murphy, Caitlin E., et al.
Publicado: (2021)

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
por: Weickert, C S, et al.
Publicado: (2013)

BDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review
por: Nieto, Rodrigo R., et al.
Publicado: (2021)

Elevated peripheral expression of neuregulin-1 (NRG1) mRNA isoforms in clozapine-treated schizophrenia patients
por: Mostaid, Md Shaki, et al.
Publicado: (2017)

Melamine disrupts spatial reversal learning and learning strategy via inhibiting hippocampal BDNF-mediated neural activity
por: Sun, Wei, et al.
Publicado: (2021)

Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia
por: Harris, Laura W, et al.
Publicado: (2009)

Dopaminergic therapy removal differentially effects learning in schizophrenia and Parkinson’s disease
por: Weickert, Thomas W., et al.
Publicado: (2013)

Attention to Irrelevant Cues Is Related to Positive Symptoms in Schizophrenia
por: Morris, Richard, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4dkkffbqmb9r6a351esmt2o6f0